PEC vs Welgene Biotech: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Welgene Biotech (6661) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Welgene Biotech

0%+108%-31%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYWelgene BiotechYoY
Oct 2026NT$2.84 billion+102.0%NT$33.9 million+22.2%
Sep 2026NT$2.64 billion+100.0%NT$35.5 million+19.6%
Aug 2026NT$2.62 billion+105.4%NT$32.3 million-31.2%
Jul 2026NT$2.51 billion+92.6%NT$33.2 million-0.9%
Jun 2026NT$2.33 billion+94.9%NT$33.3 million+0.1%
May 2026NT$2.46 billion+108.5%NT$43.1 million+33.4%
Apr 2026NT$2.06 billion+68.3%NT$30.8 million+25.5%
Mar 2026NT$1.94 billion+64.4%NT$28.8 million+0.9%
Feb 2026NT$1.6 billion+56.7%NT$26 million-2.9%
Jan 2026NT$1.58 billion+49.8%NT$29 million+28.2%
Dec 2025NT$1.92 billion+69.9%NT$36 million+8.2%
Nov 2025NT$1.55 billion+53.0%NT$34.1 million+15.6%
Oct 2025NT$1.4 billion+53.6%NT$27.8 million+11.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16